10 clinical trials registered, 2 recruiting. Interventions under study include drug therapy, procedural interventions, other interventions, and biologic therapy. Pipeline includes 1 PHASE3, 4 PHASE2, 4 PHASE1. Research is sponsored by a mix of industry and academic institutions.

91 publications have been identified in PubMed for carcinosarcoma of the corpus uteri. Research spans Case Report / Case Series (25%), Epidemiology / Natural History (21%), and Basic Science / Preclinical (18%).

Recent Publications

• Subhash S (2026). [PMID: 42079274](https://pubmed.ncbi.nlm.nih.gov/42079274/). *bioRxiv*. [Basic Science / Preclinical]

• Bahmad HF (2026). [PMID: 41915930](https://pubmed.ncbi.nlm.nih.gov/41915930/). *International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists*. [Diagnostic / Biomarker]

• Iida Y (2026). [PMID: 41947901](https://pubmed.ncbi.nlm.nih.gov/41947901/). *Oncol Lett*. [Case Report / Case Series]

• Dzienny A (2026). [PMID: 42095053](https://pubmed.ncbi.nlm.nih.gov/42095053/). *Gynecol Oncol Rep*. [Epidemiology / Natural History]

• Vallejo-Soto JC (2026). [PMID: 41559694](https://pubmed.ncbi.nlm.nih.gov/41559694/). *BMC surgery*. [Case Report / Case Series]

• More AK (2026). [PMID: 41859487](https://pubmed.ncbi.nlm.nih.gov/41859487/). *Clinical case reports*. [Basic Science / Preclinical]

• Shen H (2026). [PMID: 42032425](https://pubmed.ncbi.nlm.nih.gov/42032425/). *Discov Oncol*. [Case Report / Case Series]

• Waeldner K (2026). [PMID: 41583123](https://pubmed.ncbi.nlm.nih.gov/41583123/). *Case reports in women's health*. [Epidemiology / Natural History]

• Yang Y (2026). [PMID: 41983511](https://pubmed.ncbi.nlm.nih.gov/41983511/). *J Pathol*. [Gene Therapy / Novel Therapeutics]

• Keser M (2026). [PMID: 41514389](https://pubmed.ncbi.nlm.nih.gov/41514389/). *BMC cancer*. [Case Report / Case Series]